Journal Description
Viruses
Viruses
is a peer-reviewed, open access journal of virology, published monthly online by MDPI. The Spanish Society for Virology (SEV), Canadian Society for Virology (CSV), Italian Society for Virology (SIV-ISV), Australasian Virology Society (AVS), Brazilian Society for Virology (BSV) and Global Virus Network (GVN) are affiliated with Viruses and their members receive a discount on the article processing charges.
- Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, MEDLINE, PMC, Embase, PubAg, and other databases.
- Journal Rank: JCR - Q2 (Virology) / CiteScore - Q1 (Infectious Diseases)
- Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 15.5 days after submission; acceptance to publication is undertaken in 2.9 days (median values for papers published in this journal in the first half of 2026).
- Recognition of Reviewers: Reviewers whose reports are timely and of high quality receive an APC discount voucher for a future publication in an MDPI journal. Become a reviewer.
- Journal Cluster of Microbiology: Acta Microbiologica Hellenica, Applied Microbiology, Bacteria, Journal of Fungi, Microorganisms, Microbiology Research, Pathogens, Viruses, Fermentation and Germs.
Impact Factor:
3.8 (2025);
5-Year Impact Factor:
3.8 (2025)
Latest Articles
Anti-HIV Potential of Origanum vulgare Compounds Targeting Viral Reverse Transcriptase with High Binding and Stability Validated by Machine Learning
Viruses 2026, 18(9), 1010; https://doi.org/10.3390/v18091010 (registering DOI) - 13 Sep 2026
Abstract
Human immunodeficiency virus (HIV) is one of the viruses that has co-evolved within human populations for a considerable time. With the evolution of new drug-resistant HIV strains, the necessity to discover novel drugs has become an issue of great concern, especially those that
[...] Read more.
Human immunodeficiency virus (HIV) is one of the viruses that has co-evolved within human populations for a considerable time. With the evolution of new drug-resistant HIV strains, the necessity to discover novel drugs has become an issue of great concern, especially those that have increased binding affinities and inhibitory activity towards RT enzymes. This study used an in silico approach to identify potential HIV-RT inhibitory candidates from Origanum vulgare (oregano). An initial in silico screening of approximately 820 compounds was conducted, and based on molecular docking-derived binding energy scores, four compounds (IMPHY000687, IMPHY007084, IMPHY004619, and IMPHY012021), with docking scores of −9.42, −9.32, −9.24, and −9.23 kcal/mol, respectively, were selected as the top-ranked phytocompounds and were subsequently validated using multiple computational approaches. These compounds were geometrically optimized using quantum-chemical calculations, and detailed interaction analyses were performed using a redocking procedure. Reproducibility of the dynamic behavior was evaluated by carrying out independent replica molecular dynamics simulations for 300 ns each for all complexes. The ligand-dependent conformational dynamics were identified using RMSD and RMSF analyses, along with variations in positional changes during simulation times. PCA and FEL analyses helped in identifying the conformations sampled by the system under study. In addition, QM/MM calculations provided complementary information on the electronic characteristics of the individual protein–ligand systems. Machine learning-based quantitative structure–activity relationship (QSAR) prediction of experimentally validated HIV-RT inhibitors was applied to predict inhibitory potency, yielding predicted pIC50 values for the selected phytochemicals compared with the reference molecule. All in all, comprehensive computational analyses have ranked these phytochemicals as HIV-RT inhibitors that need further experimental verification.
Full article
(This article belongs to the Special Issue Natural, Semisynthetic, and Synthetic Antiviral Drugs: Combating Emerging and Re-Emerging Viral Threats)
Open AccessArticle
Tree-Based Classification of COVID-19 Using NanoString Whole-Blood Immune-Response Profiles: Comparison of Full-Dataset and LOOCV-Embedded Feature Selection
by
Zeynep Burcin Yilmaz, Zeynep Kucukakcali and Sami Akbulut
Viruses 2026, 18(9), 1009; https://doi.org/10.3390/v18091009 (registering DOI) - 13 Sep 2026
Abstract
Background: Whole-blood transcriptomic profiling can capture systemic immune-response alterations associated with COVID-19 and may support host-response-based classification. However, evidence regarding the discriminatory value of targeted immune-gene panels remains limited, and in small, high-dimensional datasets, the timing of feature selection may substantially affect model
[...] Read more.
Background: Whole-blood transcriptomic profiling can capture systemic immune-response alterations associated with COVID-19 and may support host-response-based classification. However, evidence regarding the discriminatory value of targeted immune-gene panels remains limited, and in small, high-dimensional datasets, the timing of feature selection may substantially affect model performance and interpretation. Aim: This study aimed to evaluate whether NanoString Human Immunology Panel profiles could distinguish COVID-19 from healthy-control measurements and to compare full-dataset feature selection (FDFS) with leave-one-out cross-validation (LOOCV)-embedded feature selection (LEFS). Methods: Publicly available E-MTAB-8871 data comprising 579 genes and 32 whole-blood transcriptomic profiles were analyzed. The dataset included 22 longitudinal COVID-19 measurements obtained from three participants and 10 measurements obtained from 10 healthy controls. Elastic Net regularization was used for feature selection. Random Forest, XGBoost, and LightGBM classifiers were evaluated using sample-level LOOCV. Model performance was assessed using threshold-dependent, discrimination, and probability-based metrics. A separate exploratory LightGBM model was analyzed using SHapley Additive exPlanations (SHAP) to characterize feature contributions. Results: FDFS identified a fixed 40-gene set, whereas LEFS selected a mean of 42 genes per fold (range: 40–47). LightGBM correctly classified all 32 measurement-level profiles (derived from 13 unique participants: 10 healthy controls and three longitudinally sampled COVID-19 participants) in both frameworks, achieving area under the receiver operating characteristic curve (ROC-AUC) and area under the precision–recall curve (PR-AUC) values of 1.000 and Brier scores of 0.005 and 0.006 in the FDFS and LEFS frameworks, respectively. Random Forest achieved accuracies of 0.969 and 1.000, whereas XGBoost achieved an accuracy of 0.969 in both frameworks. SHAP analyses consistently identified AICDA as the dominant contributor to model predictions, followed by ARHGDIB. Conclusions: This exploratory analysis showed that targeted NanoString immune-response profiles contained a compact transcriptomic signal capable of distinguishing COVID-19 from healthy-control measurements within the analyzed dataset. These findings provide proof-of-concept evidence of internal measurement-level discrimination. However, because the COVID-19 profiles consisted of repeated measurements from only three participants, sample-level LOOCV did not constitute independent participant-level validation. External validation in larger cohorts comprising independently sampled participants is required. Given that the COVID-19 arm comprised only three independent participants, these biological findings should be regarded as hypothesis-generating and require validation in substantially larger independent cohorts.
Full article
(This article belongs to the Special Issue Coronavirus Pathogenesis and Virus-Host Interaction)
Open AccessCommunication
Detection of Respiratory Viruses in Wastewater Samples Using Commercial Multiplex PCR Assays
by
Giuseppe Sberna, Maya Petricciuolo, Barbara Camilloni, Eleonora Lalle, Agnese Carnevali, Flavia Smoquina, Alessandro Graziani, Fabiano Brillo, Lavinia Fabeni, Maria Beatrice Valli, Martina Rueca, Ermanno Federici, Fabrizio Maggi and Giulia Berno
Viruses 2026, 18(9), 1008; https://doi.org/10.3390/v18091008 (registering DOI) - 13 Sep 2026
Abstract
Wastewater-based epidemiology (WBE) has emerged as a supplement to clinical investigations, facilitating the acquisition of timely and non-invasive epidemiological data. In this study, a one-year WBE study was conducted in Perugia (Umbria, Italy) to evaluate respiratory viruses using multiplex assays. Fifty-two wastewater samples
[...] Read more.
Wastewater-based epidemiology (WBE) has emerged as a supplement to clinical investigations, facilitating the acquisition of timely and non-invasive epidemiological data. In this study, a one-year WBE study was conducted in Perugia (Umbria, Italy) to evaluate respiratory viruses using multiplex assays. Fifty-two wastewater samples were collected weekly between October 2023 and September 2024 and analyzed with the Allplex™ Respiratory Panel 2/3 (for Adenovirus (AdV), Enterovirus (EV), Metapneumovirus (MPV), Parainfluenza virus types 1/2/3/4 (PIV1–4), Bocavirus (BoV), Alphacoronavirus 229E, Alphacoronavirus NL63, Betacoronavirus OC43, and Rhinovirus (RV)) and FTD respiratory pathogens 21 (only for IFV-A and RSV). The results were descriptively compared with clinical data to explore temporal concordance between wastewater and clinical surveillance. Wastewater analysis revealed frequent detection of AdV, EV, and BoV, whereas RV was detected in 67.3% of samples. AdV, EV, and BoV were detected more frequently in wastewater than in clinical samples. RSV showed a seasonal pattern in clinical samples but was only sporadically detected in wastewater, whereas PIVs were detected more frequently in clinical samples than in wastewater. By descriptive comparison, IFV-A, MPV, and non-SARS-CoV-2 coronaviruses showed peaks occurring in similar periods in wastewater and clinical samples. These results support the potential of WBE as a complementary tool to traditional clinical surveillance and suggest that commercial multiplex assays may be useful for broad, exploratory screening of respiratory viral targets in wastewater.
Full article
(This article belongs to the Special Issue Wastewater-Based Epidemiology and Viral Surveillance)
Open AccessReview
Integrating Epidemiology, Immunology, and Host Genetics for Controlling Peste des Petits Ruminants in Goats
by
Md Aminul Islam, Saifur Rahman, Md. Shafiqul Islam, Sharmin Aqter Rony, Asep Gunawan, Hari Om Pandey, Md. Taohidul Islam, A. K. M. Anisur Rahman, Md. Abu Hadi Noor Ali Khan, Julio Villena, Haruki Kitazawa and Muhammad Jasim Uddin
Viruses 2026, 18(9), 1007; https://doi.org/10.3390/v18091007 (registering DOI) - 13 Sep 2026
Abstract
Peste des petits ruminants (PPR) is a highly contagious transboundary viral disease of sheep and goats that causes major economic losses and livelihood disruption across Africa, the Middle East, and Asia. Goats are often more severely affected than sheep, particularly in endemic smallholder
[...] Read more.
Peste des petits ruminants (PPR) is a highly contagious transboundary viral disease of sheep and goats that causes major economic losses and livelihood disruption across Africa, the Middle East, and Asia. Goats are often more severely affected than sheep, particularly in endemic smallholder systems, where high turnover, nutritional stress, and limited veterinary infrastructure sustain viral transmission. Despite effective live attenuated vaccines and the ongoing FAO–WOAH Global Eradication Programme, PPR remains widely distributed, indicating that vaccination alone is insufficient without understanding of host, viral, and environmental determinants of disease persistence. This review synthesizes current knowledge on three interrelated pillars of PPR prevention and control in goats: epidemiology, immunology, and host genetics. We summarize the epidemiological drivers of PPR transmission and how these factors shape disease burden in endemic settings. We review the immunobiology of PPR virus (PPRV) infection and vaccination, focusing on innate antiviral sensing, adaptive immune protection, virus-induced immunosuppression, and field determinants of vaccine performance. Finally, we examine the emerging evidence for host genetic resilience to PPR, with emphasis on immunogenomic and transcriptomic findings and the relevance of indigenous breeds such as the Black Bengal goat as genomic resources. Current evidence suggests that genetic resilience to PPR is likely polygenic and remains insufficiently characterized, though genomic and transcriptomic tools offer opportunities to identify markers of reduced susceptibility, milder disease, or improved vaccine response. Sustainable control of PPR in goats will require integrated strategies combining mass vaccination, surveillance, improved husbandry, and host-focused immunogenomic research to strengthen herd resilience and accelerate progress toward global eradication.
Full article
(This article belongs to the Special Issue Veterinary Virology: Unraveling Host–Pathogen Interactions for Animal Health)
►▼
Show Figures

Figure 1
Open AccessArticle
Weekly HBsAg Decline Dynamics During Combination Therapy with Interferon and Nucleos(t)ide Analogs: A Retrospective Real-World Study
by
Ziyuan Yi, Zhuoran Huang, Caixia Duan, Xinru Hu, Dongyang Chen, Jie Zhang, Kuancheng Liu, Xiangjun Du, Caijun Sun and Guangyu Huang
Viruses 2026, 18(9), 1006; https://doi.org/10.3390/v18091006 (registering DOI) - 12 Sep 2026
Abstract
Functional cure, defined as sustained hepatitis B surface antigen (HBsAg) loss, remains a major goal in chronic hepatitis B (CHB) management. HBsAg kinetics during interferon (IFN)-based therapy are associated with treatment response and prognosis, but real-world data on weekly HBsAg dynamics remain limited.
[...] Read more.
Functional cure, defined as sustained hepatitis B surface antigen (HBsAg) loss, remains a major goal in chronic hepatitis B (CHB) management. HBsAg kinetics during interferon (IFN)-based therapy are associated with treatment response and prognosis, but real-world data on weekly HBsAg dynamics remain limited. This retrospective real-world study enrolled 533 CHB patients treated with IFN monotherapy or IFN plus tenofovir disoproxil fumarate (TDF), tenofovir alafenamide (TAF), or entecavir (ETV). Weekly HBsAg levels up to week 24 were analyzed using propensity score matching (PSM), subgroup analyses, and generalized estimating equations (GEEs). HBsAg kinetics showed marked heterogeneity, with some patients exhibiting transient early increases. Lower baseline HBsAg levels and rapid early decline were strongly associated with HBsAg loss. After PSM, IFN monotherapy and combination therapy showed comparable HBsAg decline trajectories. The three NA regimens demonstrated similar overall kinetics, although subgroup differences were observed by sex, immune activity, HBV DNA status, and prior treatment. TDF showed a faster decline in females, whereas ETV declined faster in males and immune-active patients. In conclusion, HBsAg kinetics during IFN-based therapy are highly heterogeneous and mainly influenced by baseline HBsAg levels, early on-treatment decline, and host factors. Weekly HBsAg monitoring may help predict treatment response and guide individualized CHB management.
Full article
(This article belongs to the Section Human Virology and Viral Diseases)
►▼
Show Figures

Figure 1
Open AccessArticle
miR-26a-5p Activates Antiviral Innate Immunity via Direct Binding and Activation of RIG-I
by
Jiasong Xiong, Xian Lin, Wei Tang, Lili Wu, Qin Chen, Mengke Li, Xindi Huang, Lianzhong Zhao and Shiyun Chen
Viruses 2026, 18(9), 1005; https://doi.org/10.3390/v18091005 (registering DOI) - 12 Sep 2026
Abstract
Emerging evidence has revealed the critical roles of microRNAs (miRNAs) in the regulation of innate immune responses. Nevertheless, it remains poorly understood whether specific miRNAs can directly modulate retinoic acid-inducible gene I (RIG-I), a principal sensor of cytoplasmic viral RNA and a key
[...] Read more.
Emerging evidence has revealed the critical roles of microRNAs (miRNAs) in the regulation of innate immune responses. Nevertheless, it remains poorly understood whether specific miRNAs can directly modulate retinoic acid-inducible gene I (RIG-I), a principal sensor of cytoplasmic viral RNA and a key initiator of antiviral innate immunity. In this study, we identified miR-26a-5p as a potent activator of the innate antiviral immune responses. Notably, this activation operates independently of the canonical miRNA pathways of translational repression and mRNA degradation. Instead, we demonstrated that miR-26a-5p exerts its immunostimulatory effects by specifically binding to the RIG-I receptor. RNA immunoprecipitation and RNA pull-down assays confirmed a direct physical interaction between miR-26a-5p and the RIG-I protein. Subsequent site-directed mutagenesis verified that an AU-rich motif is critical for miR-26a-5p-driven RIG-I activation. Viral challenge experiments demonstrated that miR-26a-5p confers broad-spectrum, RIG-I-dependent antiviral activity against both DNA viruses (herpes simplex virus type 1 and Kaposi’s sarcoma-associated herpesvirus) and RNA viruses (influenza A virus and respiratory syncytial virus). Collectively, our study indicates that miR-26a-5p may serve as a ligand that binds to and activates the RIG-I receptor. This discovery uncovers a previously unrecognized mechanism through which host miRNAs regulate antiviral innate immunity.
Full article
(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
►▼
Show Figures

Figure 1
Open AccessArticle
Clinical Characteristics, Viral Etiology, Management, and Prognosis of Pediatric Fulminant Myocarditis: A 10-Year Single-Center Study
by
Qingli Yang, Lijing Ye, Liting Wang, Yi Zhang, Yi Zhu and Jun Shen
Viruses 2026, 18(9), 1004; https://doi.org/10.3390/v18091004 (registering DOI) - 12 Sep 2026
Abstract
Background: Fulminant myocarditis (FM) is a life-threatening inflammatory cardiac disease in children, frequently triggered by viral infections. Although mechanical circulatory support has improved short-term survival, data on viral etiology and long-term outcomes remain limited, particularly in Asian populations. Methods: We conducted a mixed
[...] Read more.
Background: Fulminant myocarditis (FM) is a life-threatening inflammatory cardiac disease in children, frequently triggered by viral infections. Although mechanical circulatory support has improved short-term survival, data on viral etiology and long-term outcomes remain limited, particularly in Asian populations. Methods: We conducted a mixed retrospective–prospective analysis of pediatric FM patients at the Children’s Hospital of Fudan University from 2015 to 2025. Clinical data from 2015 to 2023 were collected retrospectively, while data from 2024 onward were collected prospectively. Clinical data, microbiological findings (PCR and metagenomic next-generation sequencing), treatment strategies, and outcomes were extracted from electronic medical records. Follow-up data for survivors were collected through December 2025. Results: A total of 53 children with FM were included. Median age was 91.5 months; 43.4% were male, and 56.6% were female. Common presenting symptoms included fever (64.2%) and vomiting (56.6%). Microbiological evidence was identified in 11 patients (20.8%), with rhinovirus (5.7%) and influenza virus (5.7%) being the most frequent, followed by enterovirus (3.8%) in peripheral specimens. During hospitalization, 79.2% required mechanical ventilation, 64.2% received extracorporeal membrane oxygenation (ECMO), and 45.3% underwent continuous renal replacement therapy (CRRT). Intravenous immunoglobulin (IVIG) was administered to 84.9%. In-hospital mortality was 13.2% (7/53), and 17.0% (9/53) of patients were discharged against medical advice (DAMA). Among 35 followed patients (median 12.4 months), most achieved favorable cardiac recovery; however, persistent conduction abnormalities, structural cardiac changes, and neurological sequelae were observed in a minority. Conclusions: Pediatric FM carries substantial in-hospital morbidity and resource utilization, despite favorable recovery rates in most survivors. The low pathogen detection rate in peripheral blood and the lack of endomyocardial tissue sampling preclude definitive conclusions regarding the underlying etiology, whether active viral replication or immune-mediated injury predominates. Endomyocardial biopsy-based investigations are urgently needed to clarify the underlying pathobiology.
Full article
(This article belongs to the Special Issue Extrapulmonary Manifestations of Respiratory Viruses)
►▼
Show Figures

Figure 1
Open AccessArticle
Two Pentaplex Real-Time Fluorescent PCR Assays for Simultaneous Detection of Ten Ovine Respiratory and Reproductive Pathogens
by
Suqiu Wang, Zilong Bai, Benyi Wan, Tong Ren, Wei Zhang, Liwei Xu, Zhiqiang Gao, Congliang Deng, Sile Du, Dan Wu, Jing Pu, Xiangpeng Zhao, Jiawei Zhang, Quanguo Liu, Lin Wang, Ke Liu and Xiju Shi
Viruses 2026, 18(9), 1003; https://doi.org/10.3390/v18091003 - 11 Sep 2026
Abstract
We developed and evaluated two pentaplex real-time fluorescent PCR assays (Panel 1/Panel 2) for simultaneous detection of ten ovine pathogens. Panel 1 targets respiratory pathogens: Bluetongue virus (BTV), Foot-and-mouth disease virus (FMDV), Schmallenberg virus (SBV), Peste des petits ruminants virus (PPRV), and Sheep
[...] Read more.
We developed and evaluated two pentaplex real-time fluorescent PCR assays (Panel 1/Panel 2) for simultaneous detection of ten ovine pathogens. Panel 1 targets respiratory pathogens: Bluetongue virus (BTV), Foot-and-mouth disease virus (FMDV), Schmallenberg virus (SBV), Peste des petits ruminants virus (PPRV), and Sheep pox virus-Goat pox virus (SPPV-GTPV). Panel 2 targets reproductive pathogens: Border disease virus (BDV), Brucella spp. (Bru), Toxoplasma gondii (T. gondii), Chlamydia abortus (C. abortus), and Caprine arthritis-encephalitis virus (CAEV). Each panel uses six fluorescent channels for detection. Validation using reference pathogens and plasmids confirmed that the assay can effectively detect the target pathogens. The Limit of Detection at 95% probability (LOD95) ranged from 2.9 to 6.1 copies/μL for all targets, with correlation coefficients (R2) greater than 0.99. The intra-assay and inter-assay coefficients of variation (CV) were less than 1.5% at both high (105 copies/μL) and low (103 copies/μL) template concentrations. Cross-reactivity tests demonstrated high specificity with no cross-detection among different targets. Validation using 620 clinical samples collected from multiple provinces in China showed strong concordance with reference methods. This multiplex assay provides a rapid, sensitive, specific, and reliable tool for the differential detection and surveillance of major ovine respiratory and reproductive pathogens.
Full article
(This article belongs to the Special Issue Viral Diseases of Domestic Animals)
►▼
Show Figures

Figure 1
Open AccessArticle
Mutations at Positions 181 and 185 Within the LCMV GP Protein Increase Tumor Cell Infectivity, Limit Induction of Type I Interferon, and Accelerate T Cell Activation
by
Michael Bergerhausen, Lisa Holnsteiner, Sarah-Kim Friedrich-Becker, Zhongwen Hu, Rosa Schmitz, Dethardt Müller, Marcus Kostka, Tim Brandenburg, Haifeng C. Xu, Cornelia Hardt, Jörg Vollmer, Philipp A. Lang and Karl Sebastian Lang
Viruses 2026, 18(9), 1002; https://doi.org/10.3390/v18091002 - 11 Sep 2026
Abstract
The lymphocytic choriomeningitis virus (LCMV) represents a strong T cell activating virus with anti-tumoral properties. In recent work, we developed an attenuated cancer cell-adapted reassortant LCMV strain carrying tumor-tropic mutations. The immunological mechanisms underlying these mutations remained unknown. Here, we passaged wild-type LCMV-WE
[...] Read more.
The lymphocytic choriomeningitis virus (LCMV) represents a strong T cell activating virus with anti-tumoral properties. In recent work, we developed an attenuated cancer cell-adapted reassortant LCMV strain carrying tumor-tropic mutations. The immunological mechanisms underlying these mutations remained unknown. Here, we passaged wild-type LCMV-WE in human lung cancer H1975 cells for 52 passages. After 29 passages, the virus acquired the GP1 mutations I181M and R185W, involved in viral receptor interactions, which remained stable throughout the subsequent 33 passages. Compared with wild-type LCMV-WE, LCMV-P52 showed increased infectivity, partly concomitant with enhanced propagation in human tumor cells. In vivo, LCMV-P52 induced reduced type I interferon (IFN-I) responses and showed accelerated expansion in CD169+ macrophages. Propagation within the splenic marginal zone correlated with accelerated priming of virus-specific CD8+ T cells and limited liver tissue damage. Mechanistic in vitro experiments showed that the I181M and R185W mutations were associated with substantially reduced infection of plasmacytoid dendritic cells (pDCs). Collectively, the I181M and R185W mutations limit systemic IFN-I induction and accelerate LCMV propagation in CD169+ macrophages, correlating with improved CD8+ T cell function and reduced liver damage. These findings provide mechanistic insight into how defined GP mutations can modulate viral tropism and antiviral immune responses.
Full article
(This article belongs to the Special Issue Oncolytic Virus Engineering for Tumor Immunotherapy)
►▼
Show Figures

Graphical abstract
Open AccessReview
The Role of Wildlife and Climate Change in the Emergence of One Health-Related Viral Diseases in Australia
by
Md. Wajed Ali, Md. Eram Hosen, Md. Mizanur Rahaman, Robert Kinobe, Martina Jelocnik and Subir Sarker
Viruses 2026, 18(9), 1001; https://doi.org/10.3390/v18091001 - 11 Sep 2026
Abstract
Wildlife-origin viral diseases are an increasing One Health challenge in Australia, with climate change emerging as a key driver of disease emergence, transmission, and spillover. Australian wildlife, particularly marsupials, birds, and bats, serve as important reservoirs of zoonotic and vector-borne viruses. However, the
[...] Read more.
Wildlife-origin viral diseases are an increasing One Health challenge in Australia, with climate change emerging as a key driver of disease emergence, transmission, and spillover. Australian wildlife, particularly marsupials, birds, and bats, serve as important reservoirs of zoonotic and vector-borne viruses. However, the combined influence of wildlife reservoirs and climate change on viral disease ecology in Australia has not been comprehensively synthesised. This review examines the epidemiology, significance, and climate sensitivity of wildlife-associated viral diseases and evaluates how climate change and variability affect reservoir host ecology, vector biology, viral persistence, and host–pathogen–vector interactions. Thirteen major wildlife-associated viruses of One Health importance were identified, with transmission predominantly involving wildlife reservoirs and mosquito vectors. Temperature and rainfall were the principal climatic drivers influencing the transmission of Ross River virus (RRV), Barmah Forest virus (BFV), Murray Valley encephalitis virus (MVEV), Japanese encephalitis virus (JEV), West Nile virus/Kunjin virus (WNV/KUNV), and avian influenza A virus (AIV). For most mosquito-borne viruses (MBVs), temperature exhibited a non-linear relationship with transmission, while above-average rainfall generally increased outbreak risk by promoting mosquito abundance, habitat availability, and reservoir host activity. Significant knowledge gaps remain in wildlife virome surveillance, climate–disease pathways, and integrated One Health surveillance. Strengthening climate-informed surveillance that integrates wildlife, vectors, genomics, epidemiology, and predictive modelling will improve outbreak preparedness and reduce the risk of viral emergence and spillover in Australia.
Full article
(This article belongs to the Section Animal Viruses)
►▼
Show Figures

Figure 1
Open AccessArticle
Occurrence of Enteric Viruses in Multi-Component Salad Bowls
by
Mariana Alves Elois, Nadine Yeramian, Daniel Perez-Alonso, Rafael Dorighello Cadamuro, Antonio Valero-Díaz, Álvaro Cañete-Reyes, Henrique Borges da Silva, Gislaine Fongaro and David Rodríguez-Lázaro
Viruses 2026, 18(9), 1000; https://doi.org/10.3390/v18091000 - 11 Sep 2026
Abstract
The expansion of e-commerce and last-mile food delivery has created an increasingly relevant but understudied context for food safety surveillance. However, the occurrence of enteric viruses in ready-to-eat (RTE) foods within this distribution context remains largely unexplored. This study aimed to investigate the
[...] Read more.
The expansion of e-commerce and last-mile food delivery has created an increasingly relevant but understudied context for food safety surveillance. However, the occurrence of enteric viruses in ready-to-eat (RTE) foods within this distribution context remains largely unexplored. This study aimed to investigate the presence of enteric viruses in multi-component RTE salad bowls obtained through last-mile delivery. The study was designed to characterize the virological status of products received through this distribution pathway, without attributing any detected contamination specifically to the delivery process itself. A total of 30 salad samples were collected in two independent batches over a two-month interval via a third-party e-commerce platform and delivered directly to the laboratory. Virus concentration was performed using a method based on ISO 15216-1:2017, followed by RNA extraction and reverse transcription quantitative polymerase chain reaction (RT-qPCR) detection of norovirus (NoV) genogroups I (GI) and II (GII), hepatitis A virus (HAV), hepatitis E virus (HEV), human astrovirus (HAstV), and rotavirus (RV). HEV-target RT-qPCR signals were observed in 5 of 30 samples (16.7%); however, all positive signals corresponded to levels below the estimated limit of quantification (LOQ). No RT-qPCR amplification was observed for the other targeted viruses. This study provides initial occurrence data for enteric viruses in multi-component RTE meals obtained through last-mile delivery and supports the inclusion of this food category and emerging distribution pathways in foodborne virus surveillance.
Full article
(This article belongs to the Special Issue Viral Aerosol Transmission, Host Environmental Exposures, and Antiviral Intervention Strategies)
►▼
Show Figures

Figure 1
Open AccessReview
Impact of HIV on Neuronal Health in the Brains of People with HIV
by
Thomas A. Angelovich, Jessica J. Kivinen, Sarah J. Byrnes, Paul R. Gorry and Melissa J. Churchill
Viruses 2026, 18(9), 999; https://doi.org/10.3390/v18090999 - 11 Sep 2026
Abstract
Despite effective viral suppression with antiretroviral therapy (ART), people with HIV (PWH) remain at increased risk of neurocognitive impairment and persistent neuroinflammation. Although neurons are not infected by HIV, they remain susceptible to the indirect effects of chronic infection, including exposure to viral
[...] Read more.
Despite effective viral suppression with antiretroviral therapy (ART), people with HIV (PWH) remain at increased risk of neurocognitive impairment and persistent neuroinflammation. Although neurons are not infected by HIV, they remain susceptible to the indirect effects of chronic infection, including exposure to viral proteins, inflammatory mediators, and glial dysfunction. The resulting neuronal injury is thought to contribute to the development and persistence of HIV-associated neurocognitive disorders in the ART era. This review examines the impact of chronic HIV infection on neuronal function, highlighting mechanisms of neuronal dysfunction driven by both viral-dependent and viral-independent pathways. We discuss the role of central nervous system viral reservoirs, neuroimmune interactions, and the neurotoxic effects of HIV proteins including Tat, gp120, and Nef. We further explore how chronic HIV infection influences synaptic integrity, neuronal metabolism, and age-related neurodegeneration. Finally, we highlight emerging biomarkers and therapeutic strategies aimed at preserving neuronal function. By integrating current evidence on both viral-dependent and viral-independent mechanisms of neuronal dysfunction, this review identifies critical knowledge gaps and future research priorities aimed at preserving neuron function and improving neurological outcomes in PWH.
Full article
(This article belongs to the Special Issue Neuropathogenesis in HIV Infection: Mechanisms and Reservoirs)
►▼
Show Figures

Figure 1
Open AccessArticle
Lymphocytic Choriomeningitis Virus Bearing GPC Mutations for Enhanced Tumor Tropism and Strong Anti-Tumor Activity
by
Sarah-Kim Friedrich-Becker, Michael Bergerhausen, Arshia Berry, Hilal Bhat, Fanghui Li, Rosa Schmitz, Lisa Holnsteiner, Dethardt Müller, Haifeng Xu, Philipp A. Lang, Karl Sebastian Lang and Jörg Vollmer
Viruses 2026, 18(9), 998; https://doi.org/10.3390/v18090998 - 11 Sep 2026
Cited by 1
Abstract
The development of effective viroimmunotherapies for cancer relies on the ability of replicating viruses to infect the entire tumor tissue and induce comprehensive inflammation within the tumor microenvironment (TME). In this study, we investigate the impact of mutations in the glycoprotein (GP) of
[...] Read more.
The development of effective viroimmunotherapies for cancer relies on the ability of replicating viruses to infect the entire tumor tissue and induce comprehensive inflammation within the tumor microenvironment (TME). In this study, we investigate the impact of mutations in the glycoprotein (GP) of lymphocytic choriomeningitis virus (LCMV) on tumor cell infectivity, replication, and the immune response. Specifically, we focus on two key positions in GP1 (181 and 185) that significantly enhance tumor cell infectivity and improve CD8+ T cell function in the GP-mutated LCMV strain LCMV P52. Our findings demonstrate that LCMV strain LCMV P52 replicates preferentially in vivo in tumors, exhibits improved tumor penetration, attracts functional CD8+ T cells more effectively to the tumor, and reprograms the tumor toward a more immunogenic microenvironment to allow for effective checkpoint inhibitor combination.
Full article
(This article belongs to the Special Issue Oncolytic Virus Engineering for Tumor Immunotherapy)
►▼
Show Figures

Figure 1
Open AccessArticle
In Vitro Assessment of Antiviral Activity of Saikosaponin B2 Against Porcine Epidemic Diarrheal Virus
by
Han Zhang, Yue Liu, Fan Zhang, Yibo Xu, Wanli Sha, Shushuai Yi and Baishuang Yin
Viruses 2026, 18(9), 997; https://doi.org/10.3390/v18090997 - 10 Sep 2026
Abstract
Porcine epidemic diarrhea virus (PEDV) variant strains lead to vaccine failures and significant economic losses in swine farming, highlighting the need for new natural small-molecule antiviral candidates. In this study, we screened a library of 45 small molecules using a cytopathic effect (CPE)-based
[...] Read more.
Porcine epidemic diarrhea virus (PEDV) variant strains lead to vaccine failures and significant economic losses in swine farming, highlighting the need for new natural small-molecule antiviral candidates. In this study, we screened a library of 45 small molecules using a cytopathic effect (CPE)-based cytoprotective assay. Saikosaponin B2 (SSB2), a triterpenoid saponin derived from Bupleuri Radix, emerged as the most promising candidate, boasting a selectivity index of 19.77, which surpasses that of most natural compounds. Dose–response tests confirmed SSB2’s concentration-dependent anti-PEDV activity, with an inhibitory plateau reached at concentrations above 60 μmol/L (μM). The 50 half-maximal effective concentration (EC50) values differed between CPE reduction and viral titer readouts, a discrepancy commonly due to varying detection sensitivities. Mechanistic assays revealed that SSB2 does not possess direct virucidal properties; instead, its antiviral efficacy depends on sustained treatment to inhibit viral adsorption and internalization. Time-of-addition experiments further demonstrated that SSB2 effectively suppresses both early viral entry and mid-stage intracellular genome replication, without affecting viral release. Notably, post-infection treatment resulted in stronger inhibition compared to continuous administration, possibly due to disrupted cellular proliferation homeostasis from prolonged exposure. Additionally, SSB2 maintained strong inhibitory effects against prevalent G2a (JL-06) and G2b (JL-08) field variants, though its efficacy was reduced for both strains and slightly weaker against JL-08 than JL-06. Overall, this study systematically characterizes SSB2’s dual-stage anti-PEDV profile and its broad-spectrum activity against spike-mutant strains, supporting SSB2 as a promising herbal lead for developing veterinary antivirals targeting variant PEDV.
Full article
(This article belongs to the Special Issue Porcine Epidemic Diarrhea Virus (PEDV): A Persistent Threat to the Global Swine Industry)
►▼
Show Figures

Figure 1
Open AccessCommunication
IRE1α Is Associated with Host Lipid Biosynthesis During Human Coronavirus OC43 Infection
by
Kaitlin N. James, Jennifer A. Miller, Hanna C. Huston, Jessica M. Oda and Susan L. Fink
Viruses 2026, 18(9), 996; https://doi.org/10.3390/v18090996 - 10 Sep 2026
Abstract
Research into the replication of human coronaviruses has surged, but much remains unknown regarding the host factors that influence disease. These viruses often activate cellular endoplasmic reticulum (ER) stress responses, benefiting from incompletely understood downstream effects. In this study, we investigated the role
[...] Read more.
Research into the replication of human coronaviruses has surged, but much remains unknown regarding the host factors that influence disease. These viruses often activate cellular endoplasmic reticulum (ER) stress responses, benefiting from incompletely understood downstream effects. In this study, we investigated the role of the host ER stress response component, inositol-requiring enzyme 1 α (IRE1α), in regulating lipid metabolism during human coronavirus OC43 (HCoV-OC43) infection. We found IRE1α-dependent induction of lipogenesis-related genes, increased metabolic intermediates, and enhanced lipophilic membrane staining during infection. Inhibition of de novo fatty acid synthesis impaired HCoV-OC43 replication, while bypassing the first steps in de novo lipogenesis with supplementation of exogenous palmitate restored viral replication in the setting of IRE1α inhibition. Together, these results suggest that lipid metabolic remodeling is associated with IRE1α signaling during coronavirus infection and targeting these host pathways may represent a potential antiviral strategy.
Full article
(This article belongs to the Special Issue Viral Regulation of Cell Death and Stress Responses)
►▼
Show Figures

Figure 1
Open AccessReview
Targeting Dengue Viral Proteins with Eco-Friendly Nanotechnology: A Promising Path for Antiviral Research
by
D Madan Kumar, R. Raj Bharath, P. Venkataraman, Kumar Sivasubramanian and Leelavathi Prakasam
Viruses 2026, 18(9), 995; https://doi.org/10.3390/v18090995 - 9 Sep 2026
Abstract
Dengue virus (DENV), a mosquito-borne pathogen belonging to the Flaviviridae family, continues to be a major global public health concern, causing millions of infections annually across tropical and subtropical regions. The virus encodes both structural and non-structural proteins that play critical roles in
[...] Read more.
Dengue virus (DENV), a mosquito-borne pathogen belonging to the Flaviviridae family, continues to be a major global public health concern, causing millions of infections annually across tropical and subtropical regions. The virus encodes both structural and non-structural proteins that play critical roles in its replication, assembly, and immune evasion. Despite substantial research progress, there is still no specific antiviral drug available, and current treatment remains primarily supportive. This review highlights the significance of DENV structural proteins (C, prM/M, and E) and non-structural proteins (NS1–NS5) as potential molecular targets for antiviral interventions. Green-synthesized silver, gold, and iron oxide nanoparticles have demonstrated strong inhibitory activity against DENV by targeting key viral proteins such as the envelope (E), NS3 protease/helicase, and NS5 RNA-dependent RNA polymerase. These nanoparticles interfere with viral entry, replication, and protein synthesis while exhibiting high biocompatibility and minimal cytotoxicity. Collectively, the findings discussed in this review underscore the promise of eco-friendly nanotechnology as a sustainable and effective platform for developing next-generation antiviral therapies against dengue virus.
Full article
(This article belongs to the Special Issue Natural, Semisynthetic, and Synthetic Antiviral Drugs: Combating Emerging and Re-Emerging Viral Threats)
►▼
Show Figures

Figure 1
Open AccessReview
Peripheral Blood Mononuclear Cell Transcriptomics in Porcine Reproductive and Respiratory Syndrome: A Window into Innate Immune Resistance and Tolerance to Viral Disease
by
Md Aminul Islam, Christiane Neuhoff, Maren Julia Pröll, Christine Große-Brinkhaus, Sharmin Aqter Rony, Ernst Tholen, Karl Schellander and Muhammad Jasim Uddin
Viruses 2026, 18(9), 994; https://doi.org/10.3390/v18090994 - 9 Sep 2026
Abstract
Peripheral blood mononuclear cells (PBMCs) are the most immunologically active and readily accessible fraction of whole blood, and they initiate host immune responses following infection and vaccination. Since PBMC transcriptomes capture diverse host–pathogen interactions, they offer a promising tool to uncover the genetic
[...] Read more.
Peripheral blood mononuclear cells (PBMCs) are the most immunologically active and readily accessible fraction of whole blood, and they initiate host immune responses following infection and vaccination. Since PBMC transcriptomes capture diverse host–pathogen interactions, they offer a promising tool to uncover the genetic drivers of viral resistance and tolerance. As a detailed case study of this principle, we examine porcine reproductive and respiratory syndrome (PRRS), which remains one of the most economically important viral diseases of swine worldwide. Following PRRS virus (PRRSV) exposure, pigs rely on two complementary defense strategies: resistance, the capacity to limit viral replication, and tolerance, the capacity to sustain performance despite infection. Since resistance and tolerance phenotypes are difficult to measure directly through experimental challenge, indirect immune-trait measurements collected after vaccination offer a practical alternative. Most transcriptomic studies of the host response to PRRSV have focused on respiratory tissues, reflecting the virus’s tropism for pulmonary macrophages. However, intramuscularly delivered modified-live PRRSV vaccine reaches the bloodstream, bypassing the lung, so PBMCs, as the frontline defense system, mount the earliest measurable innate response. This review synthesizes the current literature on PBMC transcriptome models for deciphering innate resistance and tolerance to viral disease, using PRRS as our principal worked example; presents our own approach to profiling PBMCs after PRRSV vaccination; and outlines how the field has advanced since the original candidate-gene and QTL studies of the 2010s, including the recent FDA approval of the first CD163 gene-edited PRRSV-resistant pig line, and the emergence of single-cell and multi-tissue PBMC atlases, before considering how the same PBMC-based approach could extend to other host–virus interactions.
Full article
(This article belongs to the Section Animal Viruses)
►▼
Show Figures

Figure 1
Open AccessReview
SARS-CoV-2 Drug-Resistant Mutations in Non-Structural Proteins
by
Madison Shaw and Anthony R. Fehr
Viruses 2026, 18(9), 993; https://doi.org/10.3390/v18090993 - 9 Sep 2026
Abstract
Various antiviral drug therapies have been developed for the treatment of coronaviruses, particularly SARS-CoV-2. However, the emergence of drug-resistant mutations is detrimental to clinical efficacy and global public health. Antiviral usage exerts selective pressures on viruses that manufacture an environment for resistant strains
[...] Read more.
Various antiviral drug therapies have been developed for the treatment of coronaviruses, particularly SARS-CoV-2. However, the emergence of drug-resistant mutations is detrimental to clinical efficacy and global public health. Antiviral usage exerts selective pressures on viruses that manufacture an environment for resistant strains to emerge, in some cases at a fitness cost. However, the appearance of a compensatory mutation can restore or improve viral fitness, allowing the strain to persist and spread in a population. Here we evaluate the drug resistance mechanisms of multiple SARS-CoV-2 non-structural proteins, including the main protease (Mpro) and the RNA-dependent RNA polymerase (RdRP), which drive polyprotein processing and viral RNA replication, as well as PLPro, EndoU, and Mac1, which contribute to viral replication and counter host innate immune responses. We also discuss several methods that could be used to avoid drug resistance in the future. By integrating the understanding of molecular mechanisms of antiviral treatment with surveillance of resistance-associated mutations and new drug therapies, appropriate clinical approaches can be developed to reduce the impact of drug resistance.
Full article
(This article belongs to the Special Issue Coronaviruses Pathogenesis, Immunity, and Antivirals (2nd Edition))
►▼
Show Figures

Figure 1
Open AccessArticle
Etiologies and Diagnostic Yield of Bone Marrow Evaluation in Adults Living with HIV in Venezuela: A Cross-Sectional Study
by
Lily M. Soto-Avila, Higinio Fernández-Sánchez and Alfonso J. Rodriguez-Morales
Viruses 2026, 18(9), 992; https://doi.org/10.3390/v18090992 - 9 Sep 2026
Abstract
Background: Bone marrow abnormalities in people living with HIV may reflect infectious, neoplastic, or inflammatory processes, particularly in advanced disease presenting with fever of unknown origin or unexplained cytopenias. In Latin America, contemporary data on the causes and diagnostic contribution of bone marrow
[...] Read more.
Background: Bone marrow abnormalities in people living with HIV may reflect infectious, neoplastic, or inflammatory processes, particularly in advanced disease presenting with fever of unknown origin or unexplained cytopenias. In Latin America, contemporary data on the causes and diagnostic contribution of bone marrow evaluation remain limited, especially in resource-constrained settings. Aim: To characterize the etiologies, histopathological patterns, and diagnostic contribution of bone marrow evaluation in adults living with HIV at a tertiary referral center in Venezuela. Methods: We conducted a cross-sectional study with retrospective and prospective case ascertainment among adults with confirmed HIV infection who underwent bone marrow aspiration, biopsy, or both for suspected infiltrative disease between January 2019 and April 2024. We analyzed clinical, laboratory, histopathological, microbiological, and molecular data at the index bone marrow evaluation. Test-specific denominators are reported because diagnostic investigations were not uniformly available. Results: Forty-two patients were included (35 retrospectively and 7 prospectively); 59.5% were male and the median age was 39 years (IQR: 31.75–50.0). At presentation, 67% were newly diagnosed with HIV and 79% were ART-naive; the median CD4+ T-cell count was 98.5 cells/mm3. Histopathology was evaluable in 37/42 patients; 31/37 (83.8%) showed findings compatible with infectious involvement and 6/37 (16.2%) showed malignancy. Histoplasma capsulatum was isolated in 17/35 fungal cultures (48.6%), Mycobacterium tuberculosis in 13/33 mycobacterial cultures (39.4%), and CMV PCR on bone marrow aspirate was positive in 2/3 patients tested. The final etiologic classification was infectious in 36/42 patients (85.7%) and neoplastic in 6/42 (14.3%). Conclusions: In this highly selected cohort of adults with advanced HIV disease, infectious etiologies-particularly histoplasmosis and tuberculosis-predominated. Bone marrow aspiration and biopsy, interpreted together with microbiological and molecular testing, provided clinically relevant diagnostic information in patients with prolonged fever, cytopenias, or otherwise inconclusive investigations. The findings support earlier HIV diagnosis and ART initiation and improved access to fungal, mycobacterial, and molecular diagnostics in resource-limited settings.
Full article
(This article belongs to the Special Issue HIV and HTLV Infections and Coinfections (2nd Edition))
►▼
Show Figures

Figure 1
Open AccessReview
Molecular Mechanisms of Zika Virus Entry into Host Cells
by
Haolong Cong, Xin Zhao, Wenhui Li, Rong Lei, Wenjun Zhao and Xiaodong Han
Viruses 2026, 18(9), 991; https://doi.org/10.3390/v18090991 - 9 Sep 2026
Abstract
The World Health Organization classifies mosquito-borne viruses as a major global public health threat with pandemic risk and urges all nations to strengthen pandemic preparedness. As a representative mosquito-borne flavivirus, ZIKV bears prominent pandemic capacity. Its distinctive neurotropic property and capability of vertical
[...] Read more.
The World Health Organization classifies mosquito-borne viruses as a major global public health threat with pandemic risk and urges all nations to strengthen pandemic preparedness. As a representative mosquito-borne flavivirus, ZIKV bears prominent pandemic capacity. Its distinctive neurotropic property and capability of vertical transmission create unique pathogenic hazards and transmission risks. Owing to the absence of approved vaccines and targeted antiviral therapeutics, the prevention and management of ZIKV outbreaks remain extremely challenging. Viral entry into host cells marks the very first step of productive ZIKV infection, and mechanistic investigations into this entry process lay an essential theoretical foundation for developing small-molecule agents that block ZIKV cellular entry. This review summarizes recent advances concerning ZIKV host receptor usage, membrane fusion cascades, and entry-targeted inhibitor development; systematically discusses existing inconsistencies and core controversies in cell type-dependent entry pathways, functionally redundant host receptor usage, especially the disputed AXL receptor, and unresolved molecular details of membrane fusion resulting from diverse experimental models and technical limitations; and proposes targeted future research directions to resolve these bottlenecks and clarify the context-dependent ZIKV entry mechanisms.
Full article
(This article belongs to the Special Issue Preparation for the Next Potential Pandemic—Chikungunya, Dengue, Zika and Other Viruses 2026)
►▼
Show Figures

Figure 1
Journal Menu
► ▼ Journal Menu-
- Viruses Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserHighly Accessed Articles
Latest Books
E-Mail Alert
News
Topics
Topic in
Animals, Encyclopedia, Pathogens, TropicalMed, Veterinary Sciences, Viruses, Zoonotic Diseases
Emerging and Resurging Viruses: Zoonotic Threats in a Changing World
Topic Editors: Levon Abrahamyan, Francesco VairoDeadline: 31 March 2027
Topic in
Biomedicines, Cancers, IJMS, Vaccines, Viruses, JMP
Advances in HPV-Driven Head and Neck Cancer: Pathogenesis, Treatment, and Prevention
Topic Editors: Shilpi Gupta, Bhudev Chandra Das, Prabhat KumarDeadline: 20 April 2027
Topic in
AppliedMath, BioMedInformatics, Infectious Disease Reports, Mathematics, Viruses
Modeling, Dynamics, and Control of Infectious Diseases via Complex Network Approaches
Topic Editors: Wei Yao, Hongying ShuDeadline: 30 September 2027
Topic in
Antibiotics, Diseases, Vaccines, Viruses, Epidemiologia
HIV Prevention and Treatment: A Guide to Health and Safety
Topic Editors: Olanrewaju Oladimeji, Martha ChadyiwaDeadline: 31 December 2027
Conferences
7–9 April 2027
Meet Us Virtually at the 4th International Electronic Conference on Microbiology, 7–9 April 2027

11–14 June 2027
International Veterinary Science Conference 2027: Integrating Veterinary Science and One Health for Global Wellbeing

Special Issues
Special Issue in
Viruses
Hepatitis B Virus—Mechanisms of Persistence and Progress Towards a Cure
Guest Editors: Qiong Zhao, Yongzhen LiuDeadline: 16 September 2026
Special Issue in
Viruses
The Structure and Function of Flavivirus Genes and Proteins
Guest Editors: Tadahisa Teramoto, Kay ChoiDeadline: 30 September 2026
Special Issue in
Viruses
Viruses in the Reproductive Tract
Guest Editors: Mimi Ghosh, Raina Nakova Fichorova, Christina FarrDeadline: 30 September 2026
Special Issue in
Viruses
Imaging Neurotropic Viruses
Guest Editors: Elena Criscuolo, Salla MattolaDeadline: 30 September 2026
Topical Collections
Topical Collection in
Viruses
Poxviruses
Collection Editors: Giliane de Souza Trindade, Galileu Barbosa Costa, Flavio Guimaraes da Fonseca
Topical Collection in
Viruses
Phage Therapy
Collection Editors: Nina Chanishvili, Jean-Paul Pirnay, Mikael Skurnik

